LiverLearning®: 2021 Webinar: Microbiome in NASH and Cirrhosis

In this one-hour webinar, learn about the pathophysiology of microbiome and liver disease, microbiome in NASH and microbiome in cirrhosis and other liver conditions.Suzanne Devkota Suzanne Devkota, PhD is Director of Microbiome Research at Cedars-Sinai Medical Center in Los Angeles and Assistant Professor of Medicine at UCLA, as well as an adjunct investigator at the Joslin Diabetes Center at Harvard Medical School.

Reply

Patricia Ruiz, Andres Valdivieso, Ibone Palomares, Mikel Prieto, Alberto Ventoso, Patricia Salvador, Maria Senosiain, Jose Ramon Fernandez, Milagros Testillano, Francisco Javier Bustamante, Mikel Gastaca – 10 October 2021

Gut microbiome features associated with liver fibrosis in Hispanics, a population at high risk for fatty liver disease

Suet‐Ying Kwan, Jingjing Jiao, Aron Joon, Peng Wei, Lauren E. Petty, Jennifer E. Below, Carrie R. Daniel, Xiaogang Wu, Jianhua Zhang, Robert R. Jenq, P. Andrew Futreal, Ernest T. Hawk, Joseph B. McCormick, Susan P. Fisher‐Hoch, Laura Beretta – 10 October 2021

Subscribe to